HeartFlow – New Imaging Tools in Cardiology Diagnostics
Dr. Campbell Rogers, Executive Vice President and Chief Medical Officer at HeartFlow discusses some of the latest developments in cardiovascular care, including HeartFlow’s technology, which leverages artificial intelligence to create a personalized 3D model of a patient’s heart to help physicians diagnose heart disease, the leading cause of death in the world.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Heart disease. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Heart disease and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Heart disease?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Campbell Rogers, Executive Vice President and Chief Medical Officer at HeartFlow discusses some of the latest developments in cardiovascular care, including HeartFlow’s techno…
- Key Point: Campbell Rogers is Executive Vice President and Chief Medical Officer at HeartFlow.
- Key Point: Prior to joining HeartFlow, he served as the Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation, Johnson & Johnson, where he was resp…
- Key Point: Prior to Cordis, he was Associate Professor of Medicine at Harvard Medical School and the Harvard-M.I.T.
- Key Point: Division of Health Sciences and Technology, and Director of the Cardiac Catheterization and Experimental Cardiovascular Interventional Laboratories at Brigham and Women’s Hosp…
Dr. Campbell Rogers is Executive Vice President and Chief Medical Officer at HeartFlow. Prior to joining HeartFlow, he served as the Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation, Johnson & Johnson, where he was responsible for leading investments and research in cardiovascular devices. Prior to Cordis, he was Associate Professor of Medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology, and Director of the Cardiac Catheterization and Experimental Cardiovascular Interventional Laboratories at Brigham and Women’s Hospital. He served as Principal Investigator for numerous interventional cardiology device, diagnostic and pharmacology trials, is the author of numerous journal articles, chapters, and books in the area of coronary artery and other cardiovascular diseases and was the recipient of research grant awards from the NIH and AHA. He received his A.B. from Harvard College and his M.D. from Harvard Medical School.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



